<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Reddy, Vivek Y.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Watchman Implantation without Warfarin Transition is Feasible in Patients with Atrial Fibrillation</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-09-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-9</style></pages><abstract><style  face="normal" font="default" size="100%">The first formal analysis of the ASA-Plavix (ASAP) Registry found that the Watchman left atrial appendage closure device can be used safely and effectively in patients with atrial fibrillation for whom anticoagulants are contraindicated.</style></abstract><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>